Hält derzeit Positionen bei Aurinia Pharmaceuticals Inc, Ionis Pharmaceuticals Inc and Xenon Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Director | Aurinia Pharmaceuticals Inc | 22. Februar 2018 - |
Director | Ionis Pharmaceuticals Inc | 24. September 2018 - |
Independent Director | Xenon Pharmaceuticals Inc | 1. Januar 1996 - |
President - Global Research and Development, Chief Scientific Officer | Teva Pharmaceutical Industries Ltd | 8. Mai 2012 - 31. Dezember 2017 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-09-26 | 2023-09-22 |
Abcellera Biologics Inc
(ABCL)
|
K Kauf |
20.000
+1.5%
4,9198.200 USD |
20.000 +1.5% | 4,91 | 98.200 USD | |
2023-08-09 | 2023-08-08 |
Abcellera Biologics Inc
(ABCL)
|
K Kauf |
30.000
+2.4%
5,90177.000 USD |
30.000 +2.4% | 5,90 | 177.000 USD | |
2023-03-30 | 2023-03-28 |
89Bio Inc
(ETNB)
|
K Kauf |
61.538
+inf%
16,15993.839 USD |
61.538 +inf% | 16,15 | 993.839 USD | |
2023-03-30 | 2022-04-07 |
89Bio Inc
(ETNB)
|
K Kauf |
10.000
+11.9%
3,4834.750 USD |
10.000 +11.9% | 3,48 | 34.750 USD | |
2023-03-30 | 2022-03-30 |
89Bio Inc
(ETNB)
|
K Kauf |
6.250
+8.0%
3,6222.625 USD |
6.250 +8.0% | 3,62 | 22.625 USD | |
2021-06-22 | 2021-06-22 |
Abcellera Biologics Inc
(ABCL)
|
V Verkauf |
100.000
-9.1%
25,502.550.000 USD |
100.000 -9.1% | 25,50 | 2.550.000 USD | |
2020-12-17 | 2020-12-15 |
Abcellera Biologics Inc
(ABCL)
|
K Kauf |
73.665
+165.2%
20,001.473.300 USD |
73.665 +165.2% | 20,00 | 1.473.300 USD |